⌘K

Login Start Free

Home/Filings/4/0001209191-14-077766

4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-077766

CIK 0001009356operating

View on SEC.gov Company Profile

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 4:37 PM ET

Size

7.8 KB

Accession

0001209191-14-077766

Insider Transaction Report

Form 4

Period: 2014-12-22

SALIX PHARMACEUTICALS LTDSLXP

LOGAN CAROLYN J

DirectorPresident & CEO

Transactions

Exercise/Conversion
Option to Buy Common Stock
2014-12-22−44,000→ 0 total
Exercise: $17.63Exp: 2015-06-09→ Common Stock (44,000 underlying)
Exercise/Conversion
Common Stock
2014-12-22$17.63/sh+44,000$775,720→ 703,838.2 total

Holdings

Common Stock
(indirect: By GRAT)
400,000

Footnotes (2)

[F1]The Reporting Person exercised this option on December 22, 2014 and held the resulting 44,000 shares of the Issuer's common stock.
[F2]Option is 100% vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001009356

Filing Metadata

Form type: 4
Filed: Dec 22, 7:00 PM ET
Accepted: Dec 23, 4:37 PM ET
Size: 7.8 KB

View on SEC.gov